GRACECast - LCVL- What are the options after a patient with an ALK-positive advanced NSCLC develops resistance on Alecensa-alectinib
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Mar 24, 2021 ·
5m 41s
Dr. Caroline McCoach discusses What are the options after a patient with an ALK-positive advanced NSCLC develops resistance on Alecensa-alectinib
Information
| Author | cancerGRACE |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
